Research & Development
25 September 2023 - Vaccine company Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) announced on Monday that it has signed a new contract valued at a minimum of USD32m with the US Department of Defense ...
25 September 2023 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) said on Monday that the Japanese Ministry of Health, Labor and Welfare (MHLW) has granted marketing authoris...
25 September 2023 - MicuRx Pharmaceuticals, Inc., a US-based biopharmaceutical company, announced on Friday that it has received Qualified Infectious Disease Product (QIDP) and Fast Track Designation ...
22 September 2023 - Mabwell (688062.SH), a China-based biopharmaceutical company, announced on Thursday that it has received Fast Track Designation (FTD) from the US FDA for 9MW3011 (R&D code in t...
21 September 2023 - Clinical-stage biopharmaceutical company 89bio Inc (Nasdaq:ETNB) announced on Thursday that it has been granted Breakthrough Therapy Designation (BTD) by the US Food and Drug Admin...